Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Maternal age-specific risk for trisomy 21 based on the clinical performance of NIPT and empirically derived NIPT age-specific positive and negative predictive values in Japan

A Correction to this article was published on 01 August 2018

This article has been updated

Abstract

The data collected by nation-wide study of noninvasive prenatal genetic testing (NIPT) for trisomy 21 from 21,610 pregnant women with advanced maternal age in Japan were reported. Among 188 NIPT-positive cases, 180 cases were true positive. The incidence of aneuploidy according to maternal age was estimated using a state-space model. Although, the frequency of trisomy increased exponentially with maternal age as previously reported, the maternal age-specific risk for trisomy 21 that was based on the clinical performance of NIPT was lower than the predicted risk in previous Western cohorts based on the data from invasive prenatal testing (Bayesian two-sided tail-area probability P = 0.0156). The empirical positive predictive value (PPV) of NIPT is likely to turn out higher than that of the theoretical PPV calculated from the sensitivity/specificity of the test and the incidence of trisomy 21 from this study.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3

Change history

  • 01 August 2018

    Since the advance online publication of this article, the authors of the above paper have noticed errors in the list of authors and affiliations. The article with correct author information now appears in this issue.

References

  1. 1.

    Snijders RJ, Sebire NJ, Nicolaides KH. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther. 1995;10:356–67.

    Article  PubMed  CAS  Google Scholar 

  2. 2.

    Halliday JL, Watson LF, Lumley J, et al. New estimates of Down syndrome risks at chorionic villus sampling, amniocentesis, and livebirth in women of advanced maternal age from a uniquely defined population. Prenat Diagn. 1995;15:455–65.

    Article  PubMed  CAS  Google Scholar 

  3. 3.

    Yaegashi N, Senoo M, Uehara S, et al. Age-specific incidences of chromosome abnormalities at the second trimester amniocentesis for Japanese mothers aged 35 and older: collaborative study of 5484 cases. J Hum Genet. 1998;43:85–90.

    Article  PubMed  CAS  Google Scholar 

  4. 4.

    Cuckle HS, Wald NJ, Thompson SG. Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol. 1987;94:387–402.

    Article  PubMed  CAS  Google Scholar 

  5. 5.

    Kratzer PG, Golbus MS, Schonberg SA, et al. Cytogenetic evidence for enhanced selective miscarriage of trisomy 21 pregnancies with advancing maternal age. Am J Med Genet. 1992;44:657–63.

    Article  PubMed  CAS  Google Scholar 

  6. 6.

    Hecht CA, Hook EB. Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: a proposed revised rate schedule for use in genetic and prenatal screening. Am J Med Genet. 1996;62:376–85.

    Article  PubMed  CAS  Google Scholar 

  7. 7.

    Morris JK, Wald NJ, Mutton DE, Alberman E. Comparison of models of maternal age-specific risk for Down syndrome live births. Prenat Diagn. 2003;23:252–8.

    Article  PubMed  CAS  Google Scholar 

  8. 8.

    Ricker WE. Stock and recruitment. J Fish Board Can. 1954;11:559–623.

    Article  Google Scholar 

  9. 9.

    Commandeur JJF, Koopman SJ. An introduction to state space time series analysis (practical econometrics). Oxford University Press Inc.: New York, 2007. p. 135–54

  10. 10.

    Nadeem K, Moore JE, Zhang Y, Chipman H. Integrating population dynamics models and distance sampling data: a spatial hierarchical state-space approach. Ecology. 2016;97:1735–45.

    Article  PubMed  Google Scholar 

  11. 11.

    Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med. 2012;14:296–305.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. 12.

    Samura O, Sekizawa A, Suzumori N, et al. Current status of non-invasive prenatal testing in Japan. J Obstet Gynaecol Res. 2017;43:1245–55.

    Article  PubMed  Google Scholar 

  13. 13.

    Gardner RJM, Sutherland GR, Shaffer LG. Chromosome abnormalities and genetic counseling. 4th ed. New York: Oxford University Press, Inc.; 2012. p. 405–7.

  14. 14.

    Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med. 2014;370:799–808.

    Article  PubMed  CAS  Google Scholar 

  15. 15.

    Fairbrother G, Johnson S, Musci TJ, Song K. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population. Prenat Diagn. 2013;33:580–3.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all the members of the Japan NIPT consortium, and all clinical geneticists and genetic counselors for their thoughtful cooperation on this project. This study was supported by the Grant of National Center for Child Health and Development 24-3, Japan (to AS and HS).

Funding

This work was supported by the Grant of National Center for Child Health and Development 24-3, Japan.

Study collaborators of Japan NIPT Consortium:

Takashi Kaji (The University of Tokushima Faculty of Medicine), Masanobu Ogawa (National Hospital Organization Kyushu Medical Center), Keiichi Matsubara (Ehime University School of Medicine), Haruka Hamanoue (Yokohama City University Graduate School of Medicine), Akimune Fukushima (Iwate Medical University School of Medicine), Masayuki Endo (Osaka University), Kazufumi Haino (Niigata University Medical and Dental Hospital), Hideaki Masuzaki (Nagasaki University Graduate School of Biomedical Sciences), Masaki Ogawa (Tokyo Women’s Medical University Hospital), Shinya Tairaku (Kobe University Graduate School of Medicine), Masato Mizuuchi (Sapporo Medical University School of Medicine), Yoko Okamoto (Osaka Medical Center and Research Institute for Maternal and Child Health), Yukie Kawano (Oita University), Hisashi Masuyama (Okayama University Graduate School of Medicine), Hisao Osada (Chiba University Graduate School of Medicine), Taihei Tsunemi (Nara Medical University), Kazuhisa Maeda (Shikoku Medical Center for Children and Adults), Yasuyo Kasai (Japanese Red Cross Medical Center), Reiko Neki (National Cerebral and Cardiovascular Center), Yukiko Katagiri (Toho University Omori Medical Center), Shunichiro Izumi (Tokai University School of Medicine), Setsuko Nakayama (Aiiku Hospital), Yuko Yokohama (Asahikawa Medical University), Masaya Hirose (Hyogo Prefectural Amagasaki General Medical Center), Kousuke Kawakami (National Hospital Organization Kokura Medical Center), Kiyotake Ichizuka (Showa University Northern Yokohama Hospital), Masakatsu Sase (Yamaguchi Grand Medical Center), Satoru Sakatsume (Dokkyo Medical University Koshigaya Hospital), Tomohiko Tsuruta (Kansai Rosai Hospital)

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to Takahiro Yamada.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Study Collaborators of Japan NIPT Consortium are described separately.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yamada, T., Sekizawa, A., Fujii, Y. et al. Maternal age-specific risk for trisomy 21 based on the clinical performance of NIPT and empirically derived NIPT age-specific positive and negative predictive values in Japan. J Hum Genet 63, 1035–1040 (2018). https://doi.org/10.1038/s10038-018-0453-8

Download citation

Further reading

Search

Quick links